$OLMA 3 SEC Filings

Filed On	Filing
13 Aug 2026	Form 3: O'Byrne Jason, CHIEF FINANCIAL OFFICER No securities owned
29 Apr 2026	Form 3: Raman Prakash, Director No securities owned
17 Feb 2026	Form 3: Austin Sasha Lu, VP of Finance and Controller Holds 4,488 shares of Common Stock
28 Feb 2025	Form 3: Mitchell Shawnte, CHIEF LEGAL OFFICER No securities owned
13 Jan 2025	Form 3: Bain Capital Life Sciences Investors, Llc, 10% owner and 4 others Holds 7,500,000 shares of Common Stock
17 Oct 2023	Form 3: Garland J. Scott, Director No securities owned
21 Sep 2023	Form 3: Paradigm Biocapital Advisors Lp, 10% owner and 3 others Holds 6,490,981 shares of Common Stock, par value $0.0001 per share
03 Feb 2022	Form 3: Zojwalla Naseem, CHIEF MEDICAL OFFICER No securities owned
06 Apr 2021	Form 3: Larson Yi, Director No securities owned
19 Nov 2020	Form 3: Rappaport Andrew, Director Holds 32,458 shares of Common Stock
19 Nov 2020	Form 3: Bvf Partners L P/IL, Director and 9 others
18 Nov 2020	Form 3: Wellington Biomedical Innovation Master Investors (Cayman) I L.p., 10% owner
18 Nov 2020	Form 3: Graham G. Walmsley, Director
18 Nov 2020	Form 3: Myles David C., Chief Development Officer Holds 591,821 shares of Common Stock
18 Nov 2020	Form 3: Moriarty John B, EVP, Ch. Legal Officer & Sec.
18 Nov 2020	Form 3: Mccormick Frank, Director Holds 38,222 shares of Common Stock
18 Nov 2020	Form 3: Kushner Peter J., Chief Scientific Officer Holds 1,072,752 shares of Common Stock
18 Nov 2020	Form 3: Kovacs Shane William Charles, Ch. Operating & Financial Off. Holds 358,680 shares of Common Stock
18 Nov 2020	Form 3: Hrustanovic Gorjan, Director No securities owned
18 Nov 2020	Form 3: Horning Sandra, Director No securities owned

Comments